Navigation Links
Merck and Regenstrief Institute establish evidence-based care collaboration
Date:11/8/2012

INDIANAPOLIS, Ind. -- The Regenstrief Institute and Merck, known as MSD outside the United States and Canada, have signed a five-year agreement to collaborate on a range of projects that will use clinical data to inform personalized delivery of health care. The work will explore novel methods for studying diseases and interventions for chronic conditions such as diabetes, cardiovascular disease and osteoporosis.

Ultimately, the Regenstrief-Merck collaboration seeks to improve the health of patients through data analytics, health care innovation, education and research that supports evidencebased health care.

Financial details were not disclosed.

"Regenstrief has a passion for determining how personalization of medicine can be achieved by better understanding and using health data," said Regenstrief investigator and innovations officer Jon Duke, M.D., who serves as the institute's lead investigator for the partnership. "Regenstrief brings rigorous science to clinical environments and has more than 40 years of experience as an international leader in improving health care delivery through informatics and health services research. With Merck's depth of expertise and its global reach, we hope to develop and test new approaches to care, and advance successful models of health care broadly."

Dr. Duke also is an assistant professor of medicine at the Indiana University School of Medicine.

Both Regenstrief, a medical research organization closely associated with the IU School of Medicine, and Merck, a global health care leader, are committed to generating new knowledge to improve health.

"This type of novel academic-industry collaboration can advance our understanding of a number of critical therapeutic areas, enabling novel use of health information technology to enhance drug development, medication safety and the personalization of therapeutics," said Sachin H. Jain, M.D., chief medical information and innovation officer at Merck.


'/>"/>

Contact: Cindy Fox Aisen
caisen@iupui.edu
317-843-2276
Indiana University
Source:Eurekalert

Related medicine news :

1. IU, Regenstrief automated system aims to improve child health
2. Regenstrief and IHTSDO start collaborative efforts
3. David H. Koch donates $10 million to Mount Sinais Jaffe Food Allergy Institute
4. Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder
5. The Ludwig Institute for Cancer Research announces launch of iTeos Therapeutics SA
6. A North American first at the Montreal Heart Institute
7. UC Santa Barbaras Kavli Institute receives 2 grants to explore interface of physics and biology
8. Data release from the Allen Institute for Brain Science expands online atlas offerings
9. Los Robles Hospital’s Annual Health Fair Attended by Khanna Institute
10. Patient Experience Regional Roundtables Announced by The Beryl Institute
11. Stanford Woods Institute for the Environment announces 2012 Environmental Venture Project awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... 2017 , ... Source Vitál Apothecary, a skin and body care company dedicated ... company had a successful visit to the 2017 ECRM Diet, Vitamin & Sports Nutrition ... in the nutritional, sports and health industries a chance to meet in private sessions ...
(Date:1/20/2017)... ... 20, 2017 , ... Bionic Sports Nutrition LLC, an American company devoted to ... a successful January ECRM Trade Show in Hilton Head, SC. , Bionic Sports ... to provide its products to all clients at reasonable prices. At the ECRM trade ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... enhance people’s everyday lives, recently attended the January ECRM Trade Show in Hilton ... is known for its large range of supplements that keep the body functioning ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Michael and Betsy ... Farber Cancer Institute. For Betsy, the clinical trial has been life-saving as she ... not worsened. , Betsy Brauser was diagnosed with ovarian cancer in 2009. She ...
(Date:1/20/2017)... New York, NY (PRWEB) , ... January 20, ... ... drinks – VW+ 001 and its sugar-free alternative VW+ 002. The drinks have ... the body with optimal conditions to perform during your workout. , After a ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 The ... 233.7 billion by 2025, according to a new ... is anticipated to be predominantly driven by high ... into the large-scale production of new and therapeutically ... influx of drugs at an unprecedented rate into ...
(Date:1/19/2017)... Conference Call and Webcast to Follow Vanda ... will release results for the fourth quarter of 2016 on Wednesday, ... ... at 4:30 PM ET on Wednesday, February 15, 2017, during which ... results and other corporate activities. To participate in the conference call, ...
(Date:1/19/2017)... BioTherapeutics Inc. ( Stealth ), a clinical-stage biopharmaceutical company ... additions to its senior leadership team: W. Douglas ... Daniel Geffken as interim Chief Financial Officer. In ... has been promoted to Chief Clinical Development Officer. ... Daniel to our management team, as both will be ...
Breaking Medicine Technology: